The POMC (Proopiomelanocortin) gene encodes a precursor protein that is cleaved to produce multiple biologically active peptides, including α-melanocyte stimulating hormone (α-MSH), β-endorphin, and adrenocorticotropic hormone (ACTH). Located on chromosome 2p23.3 in humans, POMC is expressed primarily in the pituitary gland, hypothalamus, and skin melanocytes . POMC-derived peptides play critical roles in energy homeostasis, stress response, pain modulation, and immune function, making this gene and its products central to understanding metabolic and neurological disorders.
¶ Gene Structure and Regulation
- Chromosomal location: 2p23.3
- Gene length: Approximately 8.5 kb
- Exons: 3 exons encoding the 267-amino acid POMC precursor
- Promoter: Contains response elements for glucocorticoids, leptin, and inflammatory cytokines
POMC expression is tightly regulated by multiple factors:
- Leptin: Positively regulates POMC transcription in hypothalamic neurons
- Glucocorticoids: Suppress POMC expression in pituitary corticotrophs
- Inflammatory Cytokines: IL-1, IL-6, and TNF-α modulate POMC expression
- Circadian Rhythm: POMC shows diurnal expression variation
¶ Protein Products and Processing
The POMC precursor is processed by prohormone convertases (PC1/3 and PC2) into distinct peptide hormones in a tissue-specific manner :
| Peptide |
Receptor |
Primary Functions |
| α-MSH |
MC1R, MC3R, MC4R |
Appetite suppression, pigmentation, anti-inflammation |
| β-Endorphin |
μ-opioid receptor |
Pain modulation, reward, analgesia |
| ACTH |
MC2R |
Adrenal steroidogenesis, stress response |
| γ-MSH |
MC3R |
Sodium balance, blood pressure regulation |
| β-MSH |
MC3R, MC4R |
Energy homeostasis |
- PC1/3 (PCSK1): Primary convertase in pituitary and hypothalamus
- PC2 (PCSK2): Secondary convertase producing β-endorphin
- ** carboxypeptidase E (CPE)**: Final processing step
The arcuate nucleus (ARC) of the hypothalamus contains the majority of central POMC-expressing neurons:
- Anatomical Location: Medialbasal hypothalamus, adjacent to the median eminence
- Connectivity: Receive inputs from other hypothalamic neurons and brainstem nuclei
- Output Targets: Paraventricular nucleus (PVN), lateral hypothalamus, preoptic area
POMC neurons exhibit unique electrophysiological characteristics:
- Leptin Sensitivity: Express leptin receptors (LepR), respond to leptin signaling
- Glucose Sensing: Monitor peripheral glucose levels
- Amino Acid Sensing: Detect changes in amino acid availability
- Synaptic Plasticity: Undergo remodeling in response to metabolic state
POMC neurons integrate metabolic signals to regulate feeding behavior:
- Anorexigenic Output: Release α-MSH to activate MC3/4 receptors, suppressing appetite
- Energy Expendience: Promote thermogenesis in brown adipose tissue
- Glucose Metabolism: Improve insulin sensitivity and glucose homeostasis
The melanocortin system consists of five G-protein coupled receptors (MC1R-MC5R):
- MC1R: Primarily in melanocytes, regulates skin pigmentation
- MC2R: Adrenal cortex, mediates ACTH effects on cortisol production
- MC3R: Central and peripheral, regulates energy homeostasis
- MC4R: Central nervous system, critical for appetite regulation
- MC5R: Exocrine glands, involved in sebaceous gland function
¶ Melanocortin Agonists and Antagonists
- Agonists: α-MSH, β-MSH, γ-MSH, setmelanotide
- Antagonists: Agouti-related protein (AGRP), agouti signaling protein (ASIP)
POMC alterations are observed in Alzheimer's disease :
- POMC Expression Changes: Reduced POMC mRNA in AD hippocampus
- Amyloid Effects: Aβ peptides may disrupt POMC neuron function
- Metabolic Dysregulation: Common in AD, may involve POMC system
- Therapeutic Potential: Melanocortin agonists being explored
POMC neurons show dysfunction in PD:
- Hypothalamic Dysfunction: POMC system impairment contributes to non-motor symptoms
- Metabolic Changes: Weight loss and appetite dysregulation in PD
- Neuroinflammation: POMC's anti-inflammatory effects may be compromised
POMC alterations in Huntington's disease:
- Metabolic Dysregulation: Abnormal energy homeostasis
- Hypothalamic Pathology: POMC neuron loss in HD models
- Therapeutic Targeting: MC4R agonists under investigation
POMC deficiency causes severe early-onset obesity :
- Complete POMC Deficiency: Rare autosomal recessive disorder
- Heterozygous Mutations: Associated with partial deficiency and obesity susceptibility
- Treatment: Setmelanotide (MC4R agonist) effective in POMC-deficient patients
- ACTH Production: POMC-derived ACTH essential for adrenal function
- Autoimmune Adrenalitis: Most common cause of primary adrenal insufficiency
¶ Inflammation and Immunity
- Anti-inflammatory Effects: α-MSH suppresses pro-inflammatory cytokine production
- Macrophage Regulation: Modulates innate immune responses
- Therapeutic Potential: α-MSH analogs in development for inflammatory conditions